Cat. No. | Product name | CAS No. |
DCG-004 |
Glycyrrhizic acid
Featured
>98%,Standard References |
1405-86-3 |
DCG-028 |
Diammonium glycyrrhizinate
>98%,Standard References |
79165-06-3 |
DCZ-254 |
Picfeltarraenin IB
>98%,Standard References |
97230-46-1 |
DCG-003 |
Glycyrrhizic acid ammonium salt
>98%,Standard References |
53956-04-0 |
DCZ-040 |
Chikusetsu saponin Ⅳa
>98%,Standard References |
51415-02-2 |
DCT-014 |
Tenacissoside H
>98%,Standard References |
191729-45-0 |
DCS-056 |
Esculentoside A
>98%,Standard References |
65497-07-6 |
DCZ-189 |
Saikosaponin B1
>98%,Standard References |
58558-08-0 |
DCC-024 |
Saikosaponin A
>98%,Standard References |
20736-09-8 |
DCC-026 |
Saikosaponin D
>98%,Standard References |
20874-52-6 |
DCC-051 |
Saikosaponin B2
>98%,Standard References |
58316-41-9 |
DCR-037 |
20(R)Ginsenoside Rg3
>98%,Standard References |
38243-03-7 |
DCR-016 |
Ginsenoside Rg2
>98%,Standard References |
52286-74-5 |
DCR-038 |
(S)Ginsenoside Rg2
>98%,Standard References |
80952-72-3 |
DCR-027 |
Ginsenoside F2
>98%,Standard References |
62025-49-4 |
DCR-010 |
Ginsenoside Rg3
>98%,Standard References |
14197-60-5 |
DCR-015 |
Ginsenoside Rg1
Featured
Ginsenoside Rg1 is one of the major active components of ginseng. Ginsenoside Rg1 displays promising effects by reducing cerebral Aβ levels. Ginsenoside Rg1 also reduces NF-κB nuclear translocation. |
22427-39-0 |
DCN-008 |
Pseudoginsenoside F11
>98%,Standard References |
69884-00-0 |
DCR-021 |
Ginsenoside Rf
>98%,Standard References |
52286-58-5 |
DCJ-020 |
8-Gingerol
>98%,Standard References |
30462-35-2 |
DCC-067 |
Theaflavine-3,3'-digallate
>98%,Standard References |
33377-72-9 |
DCM-040 |
Dryocrassin ABBA
>98%,Standard References |
12777-70-7 |
DCL-048 |
Wtlfordine
>98%,Standard References |
37239-51-3 |
DCL-053 |
Wilforine
>98%,Standard References |
11088-09-8 |
DCH-038 |
astragalosideⅠ
>98%,Standard References |
84680-75-1 |
DCE-025 |
3,29-Dibenzoyl rarounitriol
>98%,Standard References |
873001-54-8 |
DCZ-122 |
CROCIN
>98%,Standard References |
42553-65-1 |
DCX-002 |
CrocinⅠ
>98%,Standard References |
94238-00-3 |
DCC-036 |
Chonglou Saponin I
>98%,Standard References |
50773-41-6 |
DCD-072 |
liriope muscari baily saponins C
>98%,Standard References |
87480-46-4 |
DCC-037 |
Chonglou Saponin II
>98%,Standard References |
76296-72-5 |
DCL-040 |
Rebaudioside A
>98%,Standard References |
58543-16-1 |
DCA-008 |
Solamargine
>98%,Standard References |
20311-51-7 |
DCA-007 |
Solasonine
>98%,Standard References |
19121-58-5 |
DCQ-009 |
Solanesol
>98%,Standard References |
13190-97-1 |
DCZ-036 |
Anemarsaponin B
>98%,Standard References |
139051-27-7 |
DCZ-282 |
Tritetradecanoin
>98%,Standard References |
555-45-3 |
DCL-081 |
Brucine sulphate
>98%,Standard References |
4845-99-2 |
DCL-015 |
Vincristine Sulfate
>98%,Standard References |
2068-78-2 |
DCL-072 |
Vinblastine sulfate
>98%,Standard References |
143-67-9 |
DCM-063 |
Ophiopogonin C
>98%,Standard References |
911819-08-4 |
DCZ-027 |
Raddeanin(Anemodeanin) A
>98%,Standard References |
89412-79-3 |
DCC-014 |
Akebia saponin D
>98%,Standard References |
39524-08-8 |
DCS-121 |
Notoginseng triterpenes
>98%,Standard References |
88105-29-7 |
DCS-084 |
Notoginsenoside Ft1
Notoginsenoside Ft1 is a saponin isolated from Panax notoginseng; stimulator of angiogenesis. |
155683-00-4 |
DCS-002 |
Notoginsenoside R1
>98%,Standard References |
80418-24-2 |
DCA-004 |
Punicalagin
>98%,Standard References |
65995-63-3 |
DCR-032 |
GinsenosideRo
>98%,Standard References |
34367-04-9 |
DCC-025 |
Saikosaponin C
>98%,Standard References |
20736-08-7 |
DCJ-001 |
Asiaticoside
>98%,Standard References |
16830-15-2 |
DCD-051 |
Clinodiside A
>98%,Standard References |
916347-31-4 |
DCQ-018 |
Madecassoside
>98%,Standard References |
34540-22-2 |
DCQ-090 |
Aesculuside B
>98%,Standard References |
26339-92-4 |
DCR-020 |
Ginsenoside Re
>98%,Standard References |
52286-59-6 |
DCQ-065 |
Gypenoside XVII
>98%,Standard References |
80321-69-3 |
DCR-009 |
Ginsenoside Rd
>98%,Standard References |
52705-93-8 |
DCQ-025 |
Qingyangshengenin B
>98%,Standard References |
106758-54-7 |
DCT-031 |
L(+)-Asparagine monohydrate
>98%,Standard References |
5794-13-8 |
DCZ-043 |
Butylamine
>98%,Standard References |
109-73-9 |
DCF-015 |
1,4-Diaminobutane
>98%,Standard References |
110-60-1 |
DCN-024 |
Uracil
>98%,Standard References |
66-22-8 |
DCF-016 |
Fumaric acid
>98%,Standard References |
110-17-8 |
DCM-057 |
Maleic acid
>98%,Standard References |
110-16-7 |
DCB-080 |
Cytosine
>98%,Standard References |
71-30-7 |
DCN-015 |
Allantoin
>98%,Standard References |
97-59-6 |
DCH-059 |
Butane diacid
>98%,Standard References |
110-15-6 |
DCP-013 |
Malic acid
>98%,Standard References |
6915-15-7 |
DCJ-065 |
D(-)-Tartaric acid
>98%,Standard References |
526-83-0 |
DCT-032 |
L-Aspartic acid
>98%,Standard References |
56-84-8 |
DCZ-110 |
L-Asparagine
>98%,Standard References |
70-47-3 |
DCS-100 |
L-Threonine
>98%,Standard References |
72-19-5 |
DCW-031 |
Pseudoprotodioscin
>98%,Standard References |
102115-79-7 |
DCC-039 |
Polyphyllin VII
>98%,Standard References |
76296-75-8 |
DCS-124 |
Jujuboside B1
>98%,Standard References |
68144-21-8 |
DCS-046 |
Jujuboside B
>98%,Standard References |
55466-05-2 |
DCQ-047 |
Deapio-platycodin D
>98%,Standard References |
78763-58-3 |
DCJ-004 |
Gypenoside XLIX
>98%,Standard References |
94987-08-3 |
DCJ-039 |
Methylprotodioscin
>98%,Standard References |
54522-52-0 |
DCC-072 |
Hederacoside D
>98%,Standard References |
760961-03-3 |
DCC-005 |
dipsacoside B
>98%,Standard References |
33289-85-9 |
DCG-040 |
Polygalasaponin F
Polygalasaponin F, an oleanane-type triterpenoid saponin extracted from Polygala japonica, decreases the release of the inflammatory cytokine tumor necrosis factor a (TNFa). Polygalasaponin F reduces neuroinflammatory cytokine secretion through the regulation of the TLR4-PI3K/AKT-NF-kB signaling pathway . |
882664-74-6 |
DCR-014 |
Ginsenoside Rb3
>98%,Standard References |
68406-26-8 |
DCR-008 |
Ginsenoside Rc
>98%,Standard References |
11021-14-0 |
DCR-013 |
GINSENOSIDE RB2
>98%,Standard References |
11021-13-9 |
DCL-029 |
Araloside V
>98%,Standard References |
340963-86-2 |
DCL-030 |
Araloside VII
>98%,Standard References |
340982-22-1 |
DCR-012 |
Ginsenoside Rb1
>98%,Standard References |
41753-43-9 |
DCQ-038 |
Sodium Aescinate
>98%,Standard References |
20977-05-3 |
DCQ-063 |
Aescin IA
>98%,Standard References |
123748-68-5 |
DCG-043 |
Triolein
Featured
Triolein is a symmetric triacylglycerol that reduces upregulation of MMP-1 and has strong antioxidant and anti-inflammatory activities. |
122-32-7 |
DCJ-013 |
Platycodin D
>98%,Standard References |
58479-68-8 |
DCS-045 |
Jujuboside A
>98%,Standard References |
55466-04-1 |
DCS-123 |
Jujuboside D;Jujuboside A1
>98%,Standard References |
194851-84-8 |
DCP-005 |
Ubidecarenone
>98%,Standard References |
303-98-0 |
DCC-041 |
Hederasaponin B
>98%,Standard References |
36284-77-2 |
DCB-029 |
Anemoside B4
Featured
Pulchinenoside B4 is a triterpenoid glycoside that inhibits cisplatin-induced apoptosis, increases in reactive oxygen species (ROS) production, and decreases in superoxide dismutase (SOD) and catalase activities. Pulchinenoside B4 also prevents increases in plasma blood urea nitrogen (BUN) and creatinine levels -- markers of kidney injury. |
129741-57-7 |
DCH-074 |
Macranthoidin A
>98%,Standard References |
140360-29-8 |
DCG-052 |
L-Glutamine
>98%,Standard References |
56-85-9 |
DCZ-159 |
DL-Arabinose
>98%,Standard References |
147-81-9 |
DCM-066 |
D-Xylose
>98%,Standard References |
58-86-6 |
DCT-010 |
Betaine
>98%,Standard References |
107-43-7 |
DCX-056 |
L-Valine
>98%,Standard References |
72-18-4 |
DCD-076 |
L-Methionine
>98%,Standard References |
63-68-3 |
DCY-098 |
Betaine hydrochloride
>98%,Standard References |
590-46-5 |
DCA-012 |
Adonito
>98%,Standard References |
488-81-3 |
DCM-004 |
Xylitol
>98%,Standard References |
87-99-0 |
DCN-022 |
L(+)-Ornithine hydrochloride
>98%,Standard References |
3184-13-2 |
DCC-069 |
6-Hydroxypurine
>98%,Standard References |
68-94-0 |
DCH-069 |
2,6-Dihydroxypurine
>98%,Standard References |
69-89-6 |
DCJ-055 |
3-hydroxy-4H-pyran-4-one
>98%,Standard References |
496-63-9 |
DCX-060 |
Adenine
>98%,Standard References |
73-24-5 |
DCN-023 |
Guanine
>98%,Standard References |
73-40-5 |
DCP-006 |
2-Pyrrolidinecarboxylic acid
>98%,Standard References |
147-85-3 |
DCQ-040 |
L-Hydroxyproline
>98%,Standard References |
51-35-4 |
DCG-025 |
L-Glutamic acid
>98%,Standard References |
56-86-0 |
DCL-006 |
Mogroside V
>98%,Standard References |
88901-36-4 |
DCL-028 |
Araloside X
>98%,Standard References |
344911-90-6 |
DCT-011 |
Tubeimoside I
>98%,Standard References |
102040-03-9 |
DCH-028 |
4-Sulfonamide-phenylhydrazine hydrochloride
>98%,Standard References |
27918-19-0 |
DCD-027 |
Dacarbazine
>98%,Standard References |
4342-03-4 |
DCZ-246 |
Cyclohexanone
>98%,Standard References |
108-94-1 |
DCH-019 |
Wogonoside
>98%,Standard References |
51059-44-0 |
DCG-041 |
Citric acid monohydrate
>98%,Standard References |
5949-29-1 |
DCD-065 |
Allicin
>98%,Standard References |
539-86-6 |
DCL-025 |
DL-Pipecolinic acid
>98%,Standard References |
535-75-1 |
DCS-053 |
Alliin
>98%,Standard References |
556-27-4 |
DCG-050 |
L-Cystine
>98%,Standard References |
56-89-3 |
DCE-036 |
2-Methylvaleric acid
>98%,Standard References |
97-61-0 |
DCG-029 |
beta-D-Fructopyranose
>98%,Standard References |
7660-25-5 |
DCB-079 |
D-Galactose
>98%,Standard References |
59-23-4 |
DCS-094 |
Scyllitol
>98%,Standard References |
488-59-5 |
DCW-023 |
D(+)-Glucose
>98%,Standard References |
50-99-7 |
DCJ-031 |
Inositol
>98%,Standard References |
87-89-8 |
DCG-056 |
D(-)-Fructose
>98%,Standard References |
57-48-7 |
DCS-115 |
Galegine
>98%,Standard References |
20284-78-0 |
DCG-059 |
L(+)-Citrulline
>98%,Standard References |
372-75-8 |
DCS-077 |
4-Amino-4-Methylpentan-2-onehydrogenoxalate
>98%,Standard References |
625-04-7 |
DCY-146 |
L-Isoleucine
>98%,Standard References |
73-32-5 |
DCL-037 |
L-Leucine
>98%,Standard References |
61-90-5 |
DCZ-279 |
4-Hydroxyisoleucine
>98%,Standard References |
55399-93-4 |
DCT-003 |
1-Deoxynojirimycin
>98%,Standard References |
19130-96-2 |
DCL-070 |
L-Lysine
>98%,Standard References |
56-87-1 |
DCJ-010 |
L(+)-Arginine
>98%,Standard References |
74-79-3 |
DCS-037 |
L-Rhamnose monohydrate
>98%,Standard References |
6155-35-7 |
DCW-033 |
Dulcitol
>98%,Standard References |
608-66-2 |
DCG-042 |
D-Mannitol
>98%,Standard References |
69-65-8 |
DCG-027 |
Mannitol
>98%,Standard References |
87-78-5 |
DCZ-257 |
D-Glucosamine sulfate
>98%,Standard References |
29031-19-4 |
DCZ-023 |
Phytic acid
>98%,Standard References |
83-86-3 |
DCY-062 |
Nicotinic acid
>98%,Standard References |
59-67-6 |
DCZ-024 |
Calcium phytate
>98%,Standard References |
3615-82-5 |
DCY-061 |
Nicotinamide
>98%,Standard References |
98-92-0 |
DCZ-025 |
Sodium phytate
>98%,Standard References |
14306-25-3 |
DCZ-231 |
Hydroquinone
>98%,Standard References |
123-31-9 |
DCJ-044 |
5-Methyl furfural
>98%,Standard References |
620-02-0 |
DCZ-026 |
Zinc Phytate
>98%,Standard References |
63903-51-5 |
DCQ-042 |
5-Hydroxymethylfurfural
>98%,Standard References |
67-47-0 |
DCW-017 |
Vitamin C
>98%,Standard References |
50-81-7 |
DCW-004 |
Citric acid
Featured
Citric acid is a natural preservative and food tartness enhancer. Citric acid induces apoptosis and cell cycle arrest at G2/M phase and S phase in HaCaT cells. Citric acid cause oxidative damage of the liver by means of the decrease of antioxidative enzyme activities. Citric acid causes renal toxicity in mice. |
77-92-9 |
DCQ-027 |
Hydroxycitric acid
>98%,Standard References |
6205-14-7 |
DCZ-016 |
L-Histidine
>98%,Standard References |
71-00-1 |
DCQ-086 |
Guvacine hydrochloride
>98%,Standard References |
498-96-4 |
DCD-040 |
Glycerite
>98%,Standard References |
1401-55-4 |
DCM-003 |
Shikimic acid
>98%,Standard References |
138-59-0 |
DCB-084 |
Arecaidine
>98%,Standard References |
499-04-7 |
DCK-014 |
Quinic acid
>98%,Standard References |
77-95-2 |
DCY-045 |
Stachydrine hydrochloride
>98%,Standard References |
4136-37-2 |
DCC-043 |
L-Theanine
>98%,Standard References |
3081-61-6 |
DCZ-163 |
L-Quebrachitol
>98%,Standard References |
642-38-6 |
DCS-033 |
D-Pinitol
>98%,Standard References |
10284-63-6 |
DCR-030 |
L(-)-Carnitine
>98%,Standard References |
541-15-1 |
DCB-083 |
Benzaldehyde
>98%,Standard References |
100-52-7 |
DCD-058 |
p-Hydroxybenzaldehyde
>98%,Standard References |
123-08-0 |
DCB-013 |
Benzoic acid
>98%,Standard References |
65-85-0 |
DCY-032 |
Protocatechualdehyde
>98%,Standard References |
139-85-5 |
DCS-104 |
Salicylic acid
>98%,Standard References |
69-72-7 |
DCZ-021 |
Sesamol
>98%,Standard References |
533-31-3 |
DCZ-259 |
2,5-Dihydroxybenzoic acid
>98%,Standard References |
490-79-9 |
DCY-031 |
3,4-Dihydroxybenzoic acid
>98%,Standard References |
99-50-3 |
DCM-017 |
Gallic acid
>98%,Standard References |
149-91-7 |
DCH-057 |
Trigonelline
Featured
>98%,Standard References |
535-83-1 |
DCY-119 |
Trigonelline Hydrochloride
>98%,Standard References |
6138-41-6 |
DCK-009 |
Theobromine
>98%,Standard References |
83-67-0 |
DCC-042 |
Theophylline
>98%,Standard References |
58-55-9 |
DCY-148 |
Guaiacol
>98%,Standard References |
90-05-1 |
DCZ-247 |
Gipsoside
>98%,Standard References |
15588-68-8 |
DCK-013 |
Caffeine
>98%,Standard References |
58-08-2 |
DCL-042 |
4-Hydroxyphenethyl alcohol
>98%,Standard References |
501-94-0 |
DCX-055 |
4-hydroxy-3-methoxybenzylalcohol(Vanillicalcohol)
>98%,Standard References |
498-00-0 |
DCQ-079 |
3,4-Dihydroxyphenylethanol
>98%,Standard References |
10597-60-1 |
DCM-032 |
Tetramethylpyrazine
>98%,Standard References |
1124-11-4 |
DCY-057 |
Ligustrazine Hydrochloride
>98%,Standard References |
76494-51-4 |
DCB-061 |
Arecoline hydrobromide
>98%,Standard References |
300-08-3 |
DCL-067 |
Cyclen
>98%,Standard References |
294-90-6 |
DCY-168 |
6-Hydroxyindole
>98%,Standard References |
2380-86-1 |
DCY-162 |
Coixol
>98%,Standard References |
532-91-2 |
DCD-024 |
Anisic aldehyde
>98%,Standard References |
123-11-5 |
DCB-067 |
Phenylacetic acid
>98%,Standard References |
103-82-2 |
DCJ-042 |
2-Hydroxy-4-methoxybenzaldehyde
>98%,Standard References |
673-22-3 |
DCB-081 |
Mandelic acid
>98%,Standard References |
611-71-2 |